|
|
||||||||||||||||||||||||||||||||||||||||||
SurveyShould regulation of direct to consumer genetic testing be increased?BioFact:(1909) - Replacing Mendel's term factors, geneticist Wilhelm Johannsen coins the terms gene to describe the carrier of heredity, genotype to describe the genetic constitution of an organism, and phenotype to describe the actual organism. |
|
|||||||||||||||||||||||||||||||||||||||||
CEO Reading List
Biography Carl B. Feldbaum is the former president of the Biotechnology Industry Organization (BIO) which represents over 1,100 companies, academic institutions and state biotechnology centers across the United States and 31 other nations. Mr. Feldbaum came to Washington D.C. in 1973 as an assistant special prosecutor for the Watergate special prosecution force to work with Archibald Cox to investigate and prosecute the Watergate scandal. Prior to his appointment as president of BIO, Mr. Feldbaum was chief of staff to Senator Arlen Specter (R-PA) of Pennsylvania. He was also president and founder of the Palomar Corporation, a national security "think tank" in Washington, D.C. Before founding Palomar Corporation, Mr. Feldbaum was assistant to the Secretary of Energy, and served as the Inspector General for defense intelligence in the U.S. Department of Defense. In 1979, Mr. Feldbaum was awarded the Distinguished Civilian Service Medal from Defense Secretary Harold Brown. He received the Christopher Medal for his book "Looking the Tiger in the Eye: Confronting the Nuclear Threat", which was also designated by the New York Times as a notable book of the year for 1988. Mr. Feldbaum received a bachelor's degree in Biology from Princeton University and his law degree from the University of Pennsylvania Law School. Organization Profile The Biotechnology Industry Organization (BIO) is the world's largest organization to serve and represent the biotechnology industry. Carl Feldbaum's Suggested Reading List (for individuals "interested in reading for inspiration and literary excellence."
We welcome your feedback and comments. |
||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||